Boston Medical Group logo

Boston Medical Group Review

7.8
★★★★☆3.9/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10

Best for: men's health brand selling compounded semaglutide or tirzepatide at one flat price across every dose

Price is where Boston Medical Group scores best in our breakdown.

Semaglutide

$99/mo · 12-month plan rate

Tirzepatide

$149/mo · 12-month plan rate

Price checked on Boston Medical Group’s site,

What the monthly price covers

Medication

Included

Provider visits

Billed separately

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Boston Medical Group sells compounded GLP-1s through its online pharmacy storefront at 'as low as' $99/mo for semaglutide and $149/mo for tirzepatide, flat across every dose strength, with each plan sold as four weeks of medication rather than a calendar month. The same page also advertises 'Doctor-Led Weight Loss Plans Starting at $190/month', a figure that matches neither product card.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatide

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Boston Medical Group

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Boston Medical Group logo
3.9 / 5
Our editorial rating
Visit Boston Medical Group →

from $99/mo (12-month plan rate) · no insurance needed

Boston Medical Group at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$99/mo (12-month plan rate)
What's included
Medication
Availability
7 states
FDA status
No FDA warning letter on record

How we scored Boston Medical Group

Each dimension is scored algorithmically from Boston Medical Group’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

9.2/10

At $99/mo (12-month plan rate), Boston Medical Group runs about 45% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).

Effectiveness25%

8.2/10

Boston Medical Group offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.0/10

Online intake and platform experience; 3 platform features disclosed.

Trust & Safety15%

8.2/10

Key details fully confirmed by our editors; no FDA warning letters on file.

Accessibility10%

5.7/10

Boston Medical Group operates in a limited 7-state footprint, so check availability first.

Support10%

6.0/10

Boston Medical Group provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Boston Medical Group review

Last checked November 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in 7 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.

What we checked

Provider's own pricing page
$99–$149/mo across 2 dose/plan tiers (checked November 2026)
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Boston Medical Group

We walked Boston Medical Group’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Call to set up a quick consultation for a weight-loss plan.
  2. 2A licensed physician conducts a required telemedicine consultation and prescribes a personalized program.
  3. 3Prescription medication ships to you in discreet packaging.
Price shown before you startLive video visit required
  • Pricing published before intake but varies by page: semaglutide 'as little as $199/mo' (12-week $699) on one page, '$299/mo' (12-week $999, includes $100 platform fee) on another.
  • Enrollment is phone-first ('call to set up a consultation') rather than a self-serve web questionnaire.
  • A telemedicine consultation with a licensed physician is explicitly required before any prescription.
  • No lab-testing requirement or refund/cancellation policy is stated.
  • Tirzepatide is named as an option but has no separate product page or price.

Boston Medical Group customer support

GLP-1 medications Boston Medical Group offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Starting (12-month plan, $1,188; month-to-month $190)Compounded
$99/mo
semaglutide
Starting (12-month plan, $1,788; month-to-month $239)Compounded
$149/mo
tirzepatide

Ready to get started?

Plans and promotions change often, so check Boston Medical Group's current pricing and active discounts before you decide.

See Boston Medical Group pricing →

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

Boston Medical Group: a low headline price built around a fixed program

Boston Medical Group is an established telehealth practice (run out of a corporate headquarters in Huntington Beach, California, not Boston, despite the name) that sells semaglutide as a structured three-month weight-loss program rather than an open-ended monthly subscription. The reason most people land here is the number: at $99 a month (12-month plan rate) it advertises one of the lowest entry prices in the GLP-1 space, well under the category median of $179. If you are shopping purely on sticker price and want compounded medication without a lot of frills, it fits that brief. Just go in clear-eyed about what that low figure does and doesn't include.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

How the pricing works

This part trips people up. The $99 (12-month plan rate) headline covers the medication, but the consultation is not bundled in. A separate telemedicine platform fee is billed on top of the drug cost. The initial phone consult is free, which helps, but the ongoing platform charge is the line item that raises your monthly spend above the advertised rate. There is no first-month teaser price to lure you in; the rate is the rate. Because the program is sold in a fixed multi-month block rather than month to month, you are committing to a course up front rather than paying as you go. Price the whole program, not just the first invoice.

Pricing in this corner of the market moves fast, and Boston Medical Group's published rate has changed more than once. Before you hand over a card, confirm the current monthly figure, the platform fee, and the total program cost on the provider's own checkout rather than relying on a number quoted somewhere else.

The medications and how they're dispensed

Boston Medical Group prescribes compounded semaglutide and tirzepatide, the same two active ingredients found in the brand-name injectables, made by a compounding pharmacy rather than the original manufacturer. There is no brand-name Wegovy, Ozempic, or Zepbound option and no oral tablet; this is injectable compounded medication only. Compounding is what makes the low price possible, but it also means the product isn't FDA-approved the way the brand pens are, so it sits in a more lightly regulated lane. To its credit, there are no FDA warning letters or enforcement actions on file against this provider.

Where it operates

This is a regional service, not a nationwide one. Boston Medical Group treats patients in seven states: California, Texas, Washington, Michigan, New York, Colorado, and Florida. If you live outside those, you simply can't enroll, so check the list before you get attached to the price. Seven is the real footprint, whatever an older listing might claim. If you live outside those seven states, TRYM Health ships compounded GLP-1 vials to all 50, though it doesn't name its pharmacy either.

Its strengths, and what's missing

Its main draw is aggressive pricing on compounded GLP-1s from a practice that has been operating in men's and general health for years, paired with a free initial phone consult. For a budget-conscious shopper in one of its seven states, that combination is the whole pitch.

What's missing is detail. Compared with providers that spell out their compounding pharmacy, accreditation, dose-titration schedule, included clinician messaging, and refund terms, Boston Medical Group publishes relatively little about the mechanics of the program. It doesn't name a compounding-pharmacy partner or cite an accreditation, which means you're trusting the brand rather than a documented supply chain. That isn't a red flag on its own, but it is a gap. Then there's Cora Health, which lists both of its 503A pharmacies, one of them PCAB-accredited, though the company only launched in 2026. It's also the main reason this provider doesn't score higher in our scoring methodology.

Who should choose it

  • Budget-first shoppers who want the lowest realistic entry price on compounded semaglutide or tirzepatide
  • Residents of CA, TX, WA, MI, NY, CO, or FL, the only states served
  • People comfortable with compounded (non-brand) medication and a fixed multi-month program rather than month-to-month flexibility
  • Anyone who values a free initial phone consultation before committing

Who should skip it

  • Anyone who needs brand-name Wegovy, Ozempic, Mounjaro, or Zepbound, since none are offered here
  • Patients outside the seven covered states
  • Shoppers who want full transparency on the pharmacy, accreditation, and exact program terms before paying
  • People who want true pay-as-you-go billing or an all-in price with no separate platform fee

Trust and medical oversight

Boston Medical Group is a long-running medical practice with a clean regulatory record and no FDA warnings on file. Care is delivered by prescribing clinicians, and the free initial phone consult is a reasonable on-ramp. The limitation is documentation. With no published compounding partner or accreditation detail, you're relying on the practice's track record rather than a fully transparent supply chain. That's enough for a budget pick, but not enough to call it a best-in-class oversight model.

Bottom line

Boston Medical Group is a price play. If you live in one of its seven states, want compounded semaglutide or tirzepatide, and are willing to commit to a fixed multi-month program, the $99 (12-month plan rate) starting rate is hard to beat. Just remember to add the separate platform fee to get your true cost, and check the live pricing before you pay. If you need brand-name medication, nationwide access, month-to-month flexibility, or detailed transparency about the pharmacy behind your prescription, you'll be better served elsewhere.

The Bottom Line

Price is where Boston Medical Group scores best in our breakdown.

Score: 7.8/10Best for: men's health brand selling compounded semaglutide or tirzepatide at one flat price across every doseFrom: $99/mo (12-month plan rate)

Ready to start with Boston Medical Group?

From $99/mo (12-month plan rate). See current pricing and start your free consultation.

Boston Medical Group might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If you want built-in coaching and behavior-change support, consider Ro.
  • If you live outside its coverage area and need nationwide access, consider CoreAge Rx.

Head-to-head

Compare Boston Medical Group vs…

Boston Medical Group scores7.8/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Boston Medical Group Telemedicine is an established men's health network with over 20 years in operation and a self-reported patient base exceeding one million men, originally built around erectile dysfunction, premature ejaculation, and low testosterone care. The organization has expanded into GLP-1 weight loss through its SlimFitRx program, offering compounded semaglutide and tirzepatide via telehealth appointments. Corporate operations are based in Huntington Beach, California, with GLP-1 weight loss services currently available in seven states: California, Texas, Washington, Michigan, New York, Colorado, and Florida. The brand has been covered by major media including the Los Angeles Times, Chicago Tribune, Fox, and ABC.
Boston Medical Group Telemedicine has 20+ years of history in men's health and a claimed patient base exceeding one million, an unusually long operating track record for a GLP-1 provider. Founder Daniel Ha is publicly identified, and the organization has received media coverage from major national outlets. However, LegitScript certification, BBB accreditation, and named compounding pharmacy partners are not publicly disclosed for the weight loss program, and independent third-party review volume appears limited. The company's longevity in men's health is a meaningful legitimacy signal, but pharmacy transparency for the GLP-1 program is thinner than top-tier competitors. Confirm your prescribing clinician credentials and pharmacy details before enrolling.
Boston Medical Group does not display simple upfront pricing for its GLP-1 weight loss program on the public site. Costs have been cited at approximately $199 per month plus a separate telemedicine platform fee, or roughly $699 for a 12-week program (about $233 per month). These figures should be confirmed directly with Boston Medical Group before enrolling, as telehealth program pricing can change and may vary by state or treatment selection.
Boston Medical Group's weight loss program (marketed as SlimFitRx) prescribes compounded semaglutide or tirzepatide alongside lifestyle modifications such as dietary changes and regular exercise. Care is delivered via telehealth with virtual appointments, and medication ships directly to your door. The program cites average weight loss of approximately 15% of body mass with semaglutide and 22% with tirzepatide, though individual results vary. Availability is currently limited to seven states: California, Texas, Washington, Michigan, New York, Colorado, and Florida. Compounded GLP-1 medications are not FDA-approved as finished products.
Boston Medical Group doesn't use public promo or coupon codes. Third-party sites advertising "Boston Medical Group discount codes" are typically fake; any current offer applies automatically through the link on this page.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Boston Medical Group. The concerns our review flags: Limited public information on program details. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Boston Medical Group review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Boston Medical Group's current pricing

Plans from $99/mo (12-month plan rate). Start your free consultation to check eligibility and today's price.